A PROSPECTIVE PHASE II, OPEN-LABEL, SINGLE-ARM, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF SEG101 (CRIZANLIZUMAB) IN SICKLE CELL DISEASE PATIENTS WITH PRIAPISM (SPARTAN)

被引：1
|
作者：
Burnett, A. [1 ]
El Rassi, F. [2 ]
Darbari, D. [3 ]
Paulose, J. [4 ]
Laine, D. [4 ]
Purkayastha, D. [4 ]
Kato, G. [5 ]
机构：
[1] Johns Hopkins Sch Med, Baltimore, MD USA
[2] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[3] Childrens Natl Med Ctr, Washington, DC 20010 USA
[4] Novartis Pharmaceut, Basel, Switzerland
[5] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA
来源：
JOURNAL OF SEXUAL MEDICINE | 2020年 / 17卷 / 01期
关键词：
D O I：
10.1016/j.jsxm.2019.11.092
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
147
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [1] A Prospective Phase II, Open-Label, Single-Arm, Multicenter Study to Assess the Efficacy and Safety of SEG101 (Crizanlizumab) in Sickle Cell Disease Patients with Priapism (SPARTAN)
    El Rassi, Fuad A.
    Darbari, Deepika S.
    Burnett, Arthur
    Paulose, Jincy
    Laine, Dramane I.
    Purkayastha, Das
    Kato, Gregory J.
    BLOOD, 2019, 134
  • [2] Interim Analysis of a Phase 2 Trial to Assess the Efficacy and Safety of Crizanlizumab in Sickle Cell Disease Patients with Priapism (SPARTAN)
    Anderson, Alan
    El Rassi, Fuad
    DeBaun, Michael R.
    Idowu, Modupe
    Kanter, Julie
    Adam, Soheir
    Curtis, Susanna
    Liles, Darla
    Andemariam, Biree
    McLemore, Morgan L.
    Nickel, Robert Sheppard
    Ramadas, Poornima
    Paulose, Jincy
    Laine, Dramane, I
    Khan, Mahmudul
    Darbari, Deepika S.
    Burnett, Arthur L.
    BLOOD, 2022, 140 : 1636 - 1638
  • [3] Primary Analysis of Spartan: A Phase 2 Trial to Assess the Efficacy and Safety of Crizanlizumab in Patients with Sickle Cell Disease Related Priapism
    Idowu, Modupe
    DeBaun, Michael R.
    Burnett, Arthur
    Darbari, Deepika S.
    Adam, Soheir
    Anderson, Alan Randall
    Kanter, Julie
    Billett, Henny H.
    Liles, Darla K.
    Nickel, Robert S.
    Decastro, Laura M.
    Andemariam, Biree
    Blyden, Gershwin Theophilus
    Heeney, Matthew M.
    Ramadas, Poornima
    McLemore, Morgan L.
    Kolekar, Yogita
    Laine, Dramane
    Paulose, Jincy
    Sarkar, Rajendra
    Vignogna, Mary Beth
    El Rassi, Fuad
    BLOOD, 2023, 142
  • [4] Rationale and Design of a Phase II Open-Label, Multicenter Study to Assess the Pharmacokinetics and Pharmacodynamics of Crizanlizumab in Adult Patients with Sickle Cell Disease
    Kanter, Julie
    Elliott, Brian
    Weber, Denis
    Tanaka, Chiaki
    Xiang, Fang
    Ataga, Kenneth I.
    BLOOD, 2017, 130
  • [5] Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
    Ito, Shuichi
    Nishiyama, Yuya
    Sugiura, Kenkichi
    Enya, Kazuaki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2022, 26 (04) : 350 - 358
  • [6] Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
    Shuichi Ito
    Yuya Nishiyama
    Kenkichi Sugiura
    Kazuaki Enya
    Clinical and Experimental Nephrology, 2022, 26 : 350 - 358
  • [7] Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: A multicenter, open-label, single-arm phase II study
    Srimuninnimit, Vichien
    Sriuranpong, Virote
    Suwanvecho, Suthida
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (03) : 255 - 260
  • [8] Efficacy and safety of DCVAC/LuCa with chemotherapy for patients with stage IV NSCLC: A prospective, open-label, single-arm, phase II study
    Ling, X.
    Xu, J.
    Zhong, R.
    Zhong, H.
    Han, B.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S752 - S753
  • [9] Efficacy and safety of JMT103 in patients with giant cell tumor of bone: A multicenter, single-arm, open-label, phase Ib/II study.
    Niu, Xiaohui
    Wei, Feng
    Tu, Chongqi
    Huang, Gang
    Bi, Wenzhi
    Li, Jianmin
    Yao, Weitao
    Zhang, Xiaojing
    Shen, Jingnan
    Zhang, Guochuan
    Yan, Wangjun
    Yang, Jilong
    Lin, Jianhua
    Ye, Zhaoming
    Wang, Dong
    Guo, Zheng
    Tong, Zhichao
    Zhou, Yuhong
    Xu, Hairong
    Li, Tao
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [10] A Multicenter, Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of Saroglitazar in Patients With Primary Biliary Cholangitis
    Vuppalanchi, Raj
    Gonzalez-Huezo, Ma Sarai
    Payan-Olivas, Ramon
    Munoz-Espinosa, Linda E.
    Shaikh, Farheen
    Cruz-Lopez, Jose L. Pio
    Parmar, Deven
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (04) : E00327
12345